4.6 Article

Sulforaphane inhibits 4-aminobiphenyl-induced DNA damage in bladder cells and tissues

期刊

CARCINOGENESIS
卷 31, 期 11, 页码 1999-2003

出版社

OXFORD UNIV PRESS
DOI: 10.1093/carcin/bgq183

关键词

-

类别

资金

  1. National Cancer Institute [R01CA69390, R01CA112231, R01CA120533]

向作者/读者索取更多资源

Sulforaphane (SF) is a well-known chemopreventive phytochemical and occurs in broccoli and to a lesser extent in other cruciferous vegetables, whereas 4-aminobiphenyl (ABP) is a major human bladder carcinogen and is present at significant levels in tobacco smoke. Here, we show that SF inhibits ABP-induced DNA damage in both human bladder cells in vitro and mouse bladder tissue in vivo, using dG-C8-ABP as a biomarker, which is the predominant ABP-DNA adduct formed in human bladder cells and tissues. SF activates NF-E2 related factor-2 (Nrf2), which is a well-recognized chemopreventive target and activates the Nrf2-regulated cytoprotective signaling pathway. Comparison between wild-type mice and mice without Nrf2 shows that Nrf2 activation is required by SF for inhibition of ABP-induced DNA damage. Moreover, Nrf2 activation by SF in the bladder occurs primarily in the epithelium, which is the principal site of bladder cancer development. These data, together with our recent observation that SF-enriched broccoli sprout extracts strongly inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder cancer development, suggest that SF is a highly promising agent for bladder cancer prevention and provides a mechanistic insight into the repeated epidemiological observation that consumption of broccoli is inversely associated with bladder cancer risk and mortality.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

A plasma proteolysis pathway comprising blood coagulation proteases

Lu Yang, Yun Li, Arup Bhattacharya, Yuesheng Zhang

ONCOTARGET (2016)

Article Oncology

Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D

Lu Yang, Yun Li, Arup Bhattacharya, Yuesheng Zhang

ONCOTARGET (2016)

Article Multidisciplinary Sciences

PEPD is a pivotal regulator of p53 tumor suppressor

Lu Yang, Yun Li, Arup Bhattacharya, Yuesheng Zhang

NATURE COMMUNICATIONS (2017)

Review Biochemical Research Methods

Recent technical and biological development in the analysis of biomarker N-deoxyguanosine-C8-4-aminobiphenyl

Zhidan Chen, Yuesheng Zhang, Paul Vouros

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)

Article Oncology

The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer

Marilyn L. Kwan, Lawrence H. Kushi, Kim N. Danforth, Janise M. Roh, Isaac J. Ergas, Valerie S. Lee, Kimberly L. Cannavale, Teresa N. Harrison, Richard Contreras, Ronald K. Loo, David S. Aaronson, Charles P. Quesenberry, David Tritchler, Nirupa R. Ghai, Virginia P. Quinn, Christine B. Ambrosone, Yuesheng Zhang, Li Tang

CANCER CAUSES & CONTROL (2019)

Article Oncology

Strong impact of sulfotransferases on DNA adduct formation by 4-aminobiphenyl in bladder and liver in mice

Yun Li, Zhidan Chen, Joseph D. Paonessa, Walter Meinl, Arup Bhattacharya, Hansruedi Glatt, Paul Vouros, Yuesheng Zhang

CANCER MEDICINE (2018)

Article Cell Biology

A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer

Lu Yang, Yun Li, Arup Bhattacharya, Yuesheng Zhang

SCIENCE TRANSLATIONAL MEDICINE (2019)

Review Pharmacology & Pharmacy

The root cause of drug resistance in HER2-positive breast cancer and the therapeutic approaches to overcoming the resistance

Yuesheng Zhang

Summary: HER2-positive breast cancer is a common cancer type that is often treated with HER2 inhibitors. However, drug resistance frequently develops, limiting the effectiveness of treatment. Emerging therapeutics are being explored to overcome drug resistance in this subset of breast cancer.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Food Science & Technology

Effects of cooking methods on total isothiocyanate yield from cruciferous vegetables

Zinian Wang, Marilyn L. Kwan, Rachel Pratt, Janise M. Roh, Lawrence H. Kushi, Kim N. Danforth, Yuesheng Zhang, Christine B. Ambrosone, Li Tang

FOOD SCIENCE & NUTRITION (2020)

Article Biology

Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants

Lu Yang, Yun Li, Arup Bhattacharya, Yuesheng Zhang

Summary: Yang et al. discovered a mechanism to reactivate mutant p53 as a tumor suppressor by disrupting its binding to peptidase D, leading to posttranslational modifications, refolding, and restoration of tumor suppressor activities. This finding suggests a new therapeutic approach for a wide range of human tumors by inhibiting cancer cell growth through the reactivation of mutant p53's tumor suppressor functions.

COMMUNICATIONS BIOLOGY (2021)

Article Oncology

Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer

Lu Yang, Arup Bhattacharya, Yun Li, Sandra Sexton, Xiang Ling, Fengzhi Li, Yuesheng Zhang

Summary: Resistance to EGFR inhibitors in colorectal cancer is primarily due to the inability of the inhibitors to downregulate their target. The combination treatment with PEPDG278D overcomes this resistance.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Food Science & Technology

A Presurgical-Window Intervention Trial of Isothiocyanate-Rich Broccoli Sprout Extract in Patients with Breast Cancer

Zinian Wang, Chengjian Tu, Rachel Pratt, Thaer Khoury, Jun Qu, Jed W. Fahey, Susan E. McCann, Yuesheng Zhang, Yue Wu, Alan D. Hutson, Christine B. Ambrosone, Stephen B. Edge, Helen H. Cappuccino, Kazuaki Takabe, Jessica S. Young, Li Tang

Summary: This study confirms the anti-cancer activities of dietary isothiocyanates (ITCs) from cruciferous vegetables in breast cancer patients. The results show that these substances can alter the expression of tumor biomarkers, supporting their potential beneficial roles in breast cancer prognosis.

MOLECULAR NUTRITION & FOOD RESEARCH (2022)

Article Oncology

Single-Cell Analyses of a Novel Mouse Urothelial Carcinoma Model Reveal a Role of Tumor-Associated Macrophages in Response to Anti-PD-1 Therapy

Dongbo Xu, Li Wang, Kyle Wieczorek, Yali Zhang, Zinian Wang, Jianmin Wang, Bo Xu, Prashant K. Singh, Yanqing Wang, Xiaojing Zhang, Yue Wu, Gary J. Smith, Kristopher Attwood, Yuesheng Zhang, David W. Goodrich, Qiang Li

Summary: Immune checkpoint inhibitors are standard care for some advanced bladder cancer patients, but many do not respond. A novel preclinical model developed in this study showed mixed responses to anti-PD-1 immunotherapy, with responder tumors having higher macrophage infiltration, suggesting a potential role for the innate immune microenvironment in regulating ICI treatment responses.

CANCERS (2022)

Article Nutrition & Dietetics

Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle-invasive bladder cancer: findings from the Be-Well Study

Zinian Wang, Marilyn L. Kwan, Reina Haque, Maciej Goniewicz, Rachel Pratt, Valerie S. Lee, Janise M. Roh, Isaac J. Ergas, Kimberly L. Cannavale, Ronald K. Loo, David S. Aaronson, Charles P. Quesenberry, Yuesheng Zhang, Christine B. Ambrosone, Lawrence H. Kushi, Li Tang

Summary: This study aimed to investigate the associations between dietary iso-thiocyanates (ITCs) intake and the prognosis of non-muscle-invasive bladder cancer (NMIBC). The results showed that dietary ITC intake was associated with an increased risk of late recurrence in NMIBC patients. Urinary ITC metabolites and higher plasma concentrations of ITC-albumin adducts were associated with a reduced risk of late recurrence and disease progression. Increasing dietary ITC exposure through cruciferous vegetable intake could be a promising strategy to attenuate recurrence and progression risks in NMIBC patients.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2023)

Review Pharmacology & Pharmacy

Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing Both Kinase-Dependent and Kinase-Independent Functions of the Receptor

Yuesheng Zhang

Summary: EGFR is a receptor tyrosine kinase that can be activated by ligand binding, overexpression, or mutation. Various EGFR inhibitors have been developed for cancer treatment, but they only show efficacy in a few types of cancers and drug resistance is common. It has been increasingly recognized that EGFR also possesses noncanonical kinase-independent oncogenic functions, which may play a crucial role in cancer resistance to EGFR inhibitors.

PHARMACOLOGICAL REVIEWS (2023)

暂无数据